{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T20:29:09Z","timestamp":1786480149732,"version":"build-2736575974"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2022,7,15]],"date-time":"2022-07-15T00:00:00Z","timestamp":1657843200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,7,15]],"date-time":"2022-07-15T00:00:00Z","timestamp":1657843200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["P20GM103430"],"award-info":[{"award-number":["P20GM103430"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["P30 DK034989"],"award-info":[{"award-number":["P30 DK034989"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammation"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1007\/s10753-022-01713-1","type":"journal-article","created":{"date-parts":[[2022,7,15]],"date-time":"2022-07-15T05:03:02Z","timestamp":1657861382000},"page":"2570-2581","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":47,"title":["Fenofibrate Downregulates NF-\u03baB Signaling to Inhibit Pro-inflammatory Cytokine Secretion in Human THP-1 Macrophages and During Primary Biliary Cholangitis"],"prefix":"10.1007","volume":"45","author":[{"given":"Gina M.","family":"Gallucci","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bader","family":"Alsuwayt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam M.","family":"Auclair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James L.","family":"Boyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David N.","family":"Assis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4724-0576","authenticated-orcid":false,"given":"Nisanne S.","family":"Ghonem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,15]]},"reference":[{"issue":"6","key":"1713_CR1","doi-asserted-by":"publisher","first-page":"509","DOI":"10.2174\/187152811798104890","volume":"10","author":"HW Zimmermann","year":"2011","unstructured":"Zimmermann, H.W., and F. Tacke. 2011. Modification of chemokine pathways and immune cell infiltration as a novel therapeutic approach in liver inflammation and fibrosis. Inflammation & Allergy: Drug Targets 10 (6): 509\u2013536.","journal-title":"Inflammation & Allergy: Drug Targets"},{"key":"1713_CR2","doi-asserted-by":"publisher","first-page":"6565283","DOI":"10.1155\/2019\/6565283","volume":"2019","author":"Z Li","year":"2019","unstructured":"Li, Z., D. Chen, Y. Jia, Y. Feng, C. Wang, Y. Tong, R. Cui, K. Qu, C. Liu, and J. Zhang. 2019. Methane-rich saline counteracts cholestasis-induced liver damage via regulating the TLR4\/NF-kappaB\/NLRP3 inflammasome pathway. Oxidative Medicine and Cellular Longevity 2019: 6565283.","journal-title":"Oxidative Medicine and Cellular Longevity"},{"issue":"1","key":"1713_CR3","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/cr.2010.183","volume":"21","author":"G He","year":"2011","unstructured":"He, G., and M. Karin. 2011. NF-kappaB and STAT3\u2014key players in liver inflammation and cancer. Cell Research 21 (1): 159\u2013168.","journal-title":"Cell Research"},{"issue":"2","key":"1713_CR4","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1038\/sj.bjp.0706856","volume":"149","author":"S Hatziieremia","year":"2006","unstructured":"Hatziieremia, S., A.I. Gray, V.A. Ferro, A. Paul, and R. Plevin. 2006. The effects of cardamonin on lipopolysaccharide-induced inflammatory protein production and MAP kinase and NFkappaB signalling pathways in monocytes\/macrophages. British Journal of Pharmacology 149 (2): 188\u2013198.","journal-title":"British Journal of Pharmacology"},{"issue":"44","key":"1713_CR5","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000001888","volume":"94","author":"T Shi","year":"2015","unstructured":"Shi, T., T. Zhang, L. Zhang, Y. Yang, H. Zhang, and F. Zhang. 2015. The distribution and the fibrotic role of elevated inflammatory Th17 cells in patients with primary biliary cirrhosis. Medicine (Baltimore) 94 (44): e1888.","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"1713_CR6","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/s41423-020-00580-w","volume":"18","author":"Y He","year":"2021","unstructured":"He, Y., S. Hwang, Y.A. Ahmed, D. Feng, N. Li, M. Ribeiro, F. Lafdil, T. Kisseleva, G. Szabo, and B. Gao. 2021. Immunopathobiology and therapeutic targets related to cytokines in liver diseases. Cellular & Molecular Immunology 18 (1): 18\u201337.","journal-title":"Cellular & Molecular Immunology"},{"key":"1713_CR7","doi-asserted-by":"crossref","unstructured":"Ghonem, N. S.,\u00a0A.M.\u00a0Auclair,\u00a0C.L.\u00a0Hemme,\u00a0G.M.\u00a0Gallucci,\u00a0R.\u00a0de la Rosa Rodriguez,\u00a0J.L.\u00a0Boyer,\u00a0D.N.\u00a0Assis, (2020). Fenofibrate improves liver function and reduces the toxicity of the bile acid pool in patients with primary biliary cholangitis and primary sclerosing cholangitis who are partial responders to ursodiol.\u00a0Clinical Pharmacology & Therapeutics,\u00a0108\u00a0(6), 1213-1223.","DOI":"10.1002\/cpt.1930"},{"issue":"3","key":"1713_CR8","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1002\/hep.31488","volume":"73","author":"Y Gindin","year":"2021","unstructured":"Gindin, Y., C. Chung, Z. Jiang, J.Z. Zhou, J. Xu, A.N. Billin, R.P. Myers, Z. Goodman, A. Landi, M. Houghton, R.M. Green, C. Levy, K.V. Kowdley, C.L. Bowlus, A.J. Muir, and M. Trauner. 2021. A fibrosis-independent hepatic transcriptomic signature identifies drivers of disease progression in primary sclerosing cholangitis. Hepatology 73 (3): 1105\u20131116.","journal-title":"Hepatology"},{"issue":"6","key":"1713_CR9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0021381","volume":"6","author":"HW Zimmermann","year":"2011","unstructured":"Zimmermann, H.W., S. Seidler, N. Gassler, J. Nattermann, T. Luedde, C. Trautwein, and F. Tacke. 2011. Interleukin-8 is activated in patients with chronic liver diseases and associated with hepatic macrophage accumulation in human liver fibrosis. PLoS ONE 6 (6): e21381.","journal-title":"PLoS ONE"},{"issue":"1\u20132","key":"1713_CR10","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1159\/000337585","volume":"29","author":"Z Ben Ari","year":"2012","unstructured":"Ari, Z.B.,\u00a0O. Avlas, O. Pappo, V. Zilbermints, Y. Cheporko, L. Bachmetov, R. Zemel, A. Shainberg, E. Sharon, F. Grief, and E. Hochhauser. 2012. Reduced hepatic injury in Toll-like receptor 4-deficient mice following D-galactosamine\/lipopolysaccharide-induced fulminant hepatic failure. Cellular Physiology and Biochemistry 29 (1\u20132): 41\u201350.","journal-title":"Cellular Physiology and Biochemistry"},{"key":"1713_CR11","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1007\/s00011-019-01231-1","volume":"68","author":"J Korbecki","year":"2019","unstructured":"Korbecki, J., R. Bobi\u0144ski, and M. Dutka. 2019. Self-regulation of the inflammatory response by peroxisome proliferator-activated receptors. Inflammation Research 68: 443\u2013458.","journal-title":"Inflammation Research"},{"key":"1713_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2020.106386","volume":"83","author":"Y Li","year":"2020","unstructured":"Li, Y., Y. Xi, G. Tao, G. Xu, Z. Yang, X. Fu, Y. Liang, J. Qian, Y. Cui, and T. Jiang. 2020. Sirtuin 1 activation alleviates primary biliary cholangitis via the blocking of the NF-kappaB signaling pathway. International Immunopharmacology 83: 106386.","journal-title":"International Immunopharmacology"},{"issue":"9","key":"1713_CR13","first-page":"3951","volume":"23","author":"Y Yu","year":"2019","unstructured":"Yu, Y., M.P. Li, B. Xu, F. Fan, S.F. Lu, M. Pan, and H.S. Wu. 2019. A study of regulatory effects of TLR4 and NF-kappaB on primary biliary cholangitis. European Review for Medical and Pharmacological Sciences 23 (9): 3951\u20133959.","journal-title":"European Review for Medical and Pharmacological Sciences"},{"issue":"6","key":"1713_CR14","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.clinre.2018.06.009","volume":"42","author":"S Lemoinne","year":"2018","unstructured":"Lemoinne, S., A. Pares, A. Reig, K. Ben Belkacem, A.D. Kemgang Fankem, F. Gaouar, R. Poupon, C. Housset, C. Corpechot, and O. Chazouilleres. 2018. Primary sclerosing cholangitis response to the combination of fibrates with ursodeoxycholic acid: French-Spanish experience. Clinics and Research in Hepatology and Gastroenterology 42 (6): 521\u2013528.","journal-title":"Clinics and Research in Hepatology and Gastroenterology"},{"issue":"2","key":"1713_CR15","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1111\/j.1365-2036.2010.04512.x","volume":"33","author":"C Levy","year":"2011","unstructured":"Levy, C., J.A. Peter, D.R. Nelson, J. Keach, J. Petz, R. Cabrera, V. Clark, R.J. Firpi, G. Morelli, C. Soldevila-Pico, and K. Lindor. 2011. Pilot study: Fenofibrate for patients with primary biliary cirrhosis and an incomplete response to ursodeoxycholic acid. Alimentary Pharmacology & Therapeutics 33 (2): 235\u2013242.","journal-title":"Alimentary Pharmacology & Therapeutics"},{"issue":"23","key":"1713_CR16","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.1056\/NEJMoa1714519","volume":"378","author":"C Corpechot","year":"2018","unstructured":"Corpechot, C., O. Chazouilleres, A. Rousseau, A. Le Gruyer, F. Habersetzer, P. Mathurin, O. Goria, P. Potier, A. Minello, C. Silvain, A. Abergel, M. Debette-Gratien, D. Larrey, O. Roux, J.P. Bronowicki, J. Boursier, V. de Ledinghen, A. Heurgue-Berlot, E. Nguyen-Khac, F. Zoulim, I. Ollivier-Hourmand, J.P. Zarski, G. Nkontchou, S. Lemoinne, L. Humbert, D. Rainteau, G. Lefevre, L. de Chaisemartin, S. Chollet-Martin, F. Gaouar, F.H. Admane, T. Simon, and R. Poupon. 2018. A placebo-controlled trial of bezafibrate in primary biliary cholangitis. New England Journal of Medicine 378 (23): 2171\u20132181.","journal-title":"New England Journal of Medicine"},{"issue":"5","key":"1713_CR17","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1089\/107999099313866","volume":"19","author":"KA Roebuck","year":"1999","unstructured":"Roebuck, K.A. 1999. Regulation of interleukin-8 gene expression. Journal of Interferon and Cytokine Research 19 (5): 429\u2013438.","journal-title":"Journal of Interferon and Cytokine Research"},{"key":"1713_CR18","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/697972","volume":"2013","author":"A Schildberger","year":"2013","unstructured":"Schildberger, A., E. Rossmanith, T. Eichhorn, K. Strassl, and V. Weber. 2013. Monocytes, peripheral blood mononuclear cells, and THP-1 cells exhibit different cytokine expression patterns following stimulation with lipopolysaccharide. Mediators of Inflammation 2013: 697972.","journal-title":"Mediators of Inflammation"},{"issue":"6","key":"1713_CR19","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1128\/CDLI.7.6.920-924.2000","volume":"7","author":"KE Sullivan","year":"2000","unstructured":"Sullivan, K.E., J. Cutilli, L.M. Piliero, D. Ghavimi-Alagha, S.E. Starr, D.E. Campbell, and S.D. Douglas. 2000. Measurement of cytokine secretion, intracellular protein expression, and mRNA in resting and stimulated peripheral blood mononuclear cells. Clinical and Diagnostic Laboratory Immunology 7 (6): 920\u2013924.","journal-title":"Clinical and Diagnostic Laboratory Immunology"},{"key":"1713_CR20","doi-asserted-by":"publisher","first-page":"175883591986191","DOI":"10.1177\/1758835919861914","volume":"11","author":"A Lleo","year":"2019","unstructured":"Lleo, A., Y.S. de Boer, R. Liberal, and M. Colombo. 2019. The risk of liver cancer in autoimmune liver diseases. Ther Adv Med Oncol 11: 1758835919861914.","journal-title":"Ther Adv Med Oncol"},{"issue":"3","key":"1713_CR21","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1016\/j.jhep.2014.10.039","volume":"62","author":"M Pawlak","year":"2015","unstructured":"Pawlak, M., P. Lefebvre, and B. Staels. 2015. Molecular mechanism of PPARalpha action and its impact on lipid metabolism, inflammation and fibrosis in non-alcoholic fatty liver disease. Journal of Hepatology 62 (3): 720\u2013733.","journal-title":"Journal of Hepatology"},{"key":"1713_CR22","doi-asserted-by":"crossref","unstructured":"Thibaut, R.,\u00a0M.C.\u00a0Gage,\u00a0I.\u00a0Pineda\u2010Torra,\u00a0G.\u00a0Chabrier,\u00a0N.\u00a0Venteclef,\u00a0F.\u00a0Alzaid, 2021.\u00a0Liver macrophages and inflammation in physiology and physiopathology of non-alcoholic fatty liver disease.\u00a0The FEBS Journal.","DOI":"10.1111\/febs.15877"},{"key":"1713_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2172-8-1","volume":"8","author":"O Sharif","year":"2007","unstructured":"Sharif, O., V.N. Bolshakov, S. Raines, P. Newham, and N.D. Perkins. 2007. Transcriptional profiling of the LPS induced NF-kappaB response in macrophages. BMC Immunology 8: 1.","journal-title":"BMC Immunology"},{"key":"1713_CR24","doi-asserted-by":"crossref","unstructured":"Th\u00e9rien, A.,\u00a0A.\u00a0Cie\u015blak,\u00a0M.\u00a0Verreault,\u00a0M.\u00a0Perreault,\u00a0J.\u00a0Trottier,\u00a0S.\u00a0Gobeil,\u00a0O.\u00a0Barbier, 2021. Omega-3 Polyunsaturated Fatty Acid: A Pharmaco-Nutraceutical Approach to Improve the Responsiveness to Ursodeoxycholic Acid.\u00a0Nutrients\u00a013\u00a0(8), 2617.","DOI":"10.3390\/nu13082617"},{"key":"1713_CR25","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/1471-230X-7-44","volume":"7","author":"M Cindoruk","year":"2007","unstructured":"Cindoruk, M., M. Kerem, T. Karakan, B. Salman, O. Akin, M. Alper, O. Erdem, and S. Unal. 2007. Peroxisome proliferators-activated alpha agonist treatment ameliorates hepatic damage in rats with obstructive jaundice: An experimental study. BMC Gastroenterology 7: 44.","journal-title":"BMC Gastroenterology"},{"issue":"7","key":"1713_CR26","doi-asserted-by":"publisher","first-page":"3488","DOI":"10.1128\/IAI.67.7.3488-3493.1999","volume":"67","author":"MR Hill","year":"1999","unstructured":"Hill, M.R., S. Clarke, K. Rodgers, B. Thornhill, J.M. Peters, F.J. Gonzalez, and J.M. Gimble. 1999. Effect of peroxisome proliferator-activated receptor alpha activators on tumor necrosis factor expression in mice during endotoxemia. Infection and Immunity 67 (7): 3488\u20133493.","journal-title":"Infection and Immunity"},{"key":"1713_CR27","doi-asserted-by":"publisher","DOI":"10.1155\/2008\/352437","volume":"2008","author":"R Grau","year":"2008","unstructured":"Grau, R., M.D. Diaz-Munoz, C. Cacheiro-Llaguno, M. Fresno, and M.A. Iniguez. 2008. Role of peroxisome proliferator-activated receptor alpha in the control of cyclooxygenase 2 and vascular endothelial growth factor: Involvement in tumor growth. PPAR Research 2008: 352437.","journal-title":"PPAR Research"},{"issue":"49","key":"1713_CR28","doi-asserted-by":"publisher","first-page":"32833","DOI":"10.1074\/jbc.273.49.32833","volume":"273","author":"ME Poynter","year":"1998","unstructured":"Poynter, M.E., and R.A. Daynes. 1998. Peroxisome proliferator-activated receptor alpha activation modulates cellular redox status, represses nuclear factor-kappaB signaling, and reduces inflammatory cytokine production in aging. Journal of Biological Chemistry 273 (49): 32833\u201332841.","journal-title":"Journal of Biological Chemistry"},{"issue":"24","key":"1713_CR29","doi-asserted-by":"publisher","first-page":"3125","DOI":"10.1161\/01.CIR.99.24.3125","volume":"99","author":"N Marx","year":"1999","unstructured":"Marx, N., G.K. Sukhova, T. Collins, P. Libby, and J. Plutzky. 1999. PPARalpha activators inhibit cytokine-induced vascular cell adhesion molecule-1 expression in human endothelial cells. Circulation 99 (24): 3125\u20133131.","journal-title":"Circulation"},{"issue":"10","key":"1713_CR30","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1038\/ncpgasthep0602","volume":"3","author":"A Geier","year":"2006","unstructured":"Geier, A., P. Fickert, and M. Trauner. 2006. Mechanisms of disease: Mechanisms and clinical implications of cholestasis in sepsis. Nature Clinical Practice. Gastroenterology & Hepatology 3 (10): 574\u2013585.","journal-title":"Nature Clinical Practice. Gastroenterology & Hepatology"},{"issue":"6","key":"1713_CR31","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a001651","volume":"1","author":"T Lawrence","year":"2009","unstructured":"Lawrence, T. 2009. The nuclear factor NF-kappaB pathway in inflammation. Cold Spring Harbor Perspectives in Biology 1 (6): a001651.","journal-title":"Cold Spring Harbor Perspectives in Biology"},{"key":"1713_CR32","doi-asserted-by":"crossref","unstructured":"Liu, T.,\u00a0L.\u00a0Zhang,\u00a0D.\u00a0Joo,\u00a0S.C.\u00a0Sun, 2017. NF-\u03baB signaling in inflammation.\u00a0Signal transduction and targeted therapy\u00a02 (1), 1\u20139.","DOI":"10.1038\/sigtrans.2017.23"},{"issue":"8","key":"1713_CR33","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1021\/bi901948j","volume":"49","author":"DU Ferreiro","year":"2010","unstructured":"Ferreiro, D.U., and E.A. Komives. 2010. Molecular mechanisms of system control of NF-kappaB signaling by IkappaBalpha. Biochemistry 49 (8): 1560\u20131567.","journal-title":"Biochemistry"},{"key":"1713_CR34","doi-asserted-by":"crossref","unstructured":"Wu, K., and J.P. Gong. 2013. The role of Kupffer cells in the progression of acute pancreatitis. OA Emergency Medicine 1 (1): 4.","DOI":"10.13172\/2054-1902-1-1-648"},{"issue":"47","key":"1713_CR35","doi-asserted-by":"publisher","first-page":"36703","DOI":"10.1074\/jbc.M004045200","volume":"275","author":"P Delerive","year":"2000","unstructured":"Delerive, P., P. Gervois, J.C. Fruchart, and B. Staels. 2000. Induction of IkappaBalpha expression as a mechanism contributing to the anti-inflammatory activities of peroxisome proliferator-activated receptor-alpha activators. Journal of Biological Chemistry 275 (47): 36703\u201336707.","journal-title":"Journal of Biological Chemistry"},{"issue":"7\u20138","key":"1713_CR36","doi-asserted-by":"publisher","first-page":"5525","DOI":"10.1002\/jcp.29452","volume":"235","author":"N Dong","year":"2020","unstructured":"Dong, N., X. Li, C. Xue, L. Zhang, C. Wang, X. Xu, and A. Shan. 2020. Astragalus polysaccharides alleviates LPS-induced inflammation via the NF-kappaB\/MAPK signaling pathway. Journal of Cellular Physiology 235 (7\u20138): 5525\u20135540.","journal-title":"Journal of Cellular Physiology"},{"issue":"10","key":"1713_CR37","doi-asserted-by":"publisher","first-page":"7101","DOI":"10.4049\/jimmunol.179.10.7101","volume":"179","author":"RN Saha","year":"2007","unstructured":"Saha, R.N., M. Jana, and K. Pahan. 2007. MAPK p38 regulates transcriptional activity of NF-kappaB in primary human astrocytes via acetylation of p65. The Journal of Immunology 179 (10): 7101\u20137109.","journal-title":"The Journal of Immunology"},{"issue":"4","key":"1713_CR38","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.202012409","volume":"13","author":"P Novoszel","year":"2021","unstructured":"Novoszel, P., M. Holcmann, G. Stulnig,\u00a0C. De Sa Fernandes, V. Zyulina, I. Borek, M. Linder, A. Bogusch, B. Drobits, T. Bauer, C. Tam-Amersdorfer, P.M. Brunner, G. Stary, L. Bakiri, E.F. Wagner, H. Strobl, and M. Sibilia. 2021. Psoriatic skin inflammation is promoted by c-Jun\/AP-1-dependent CCL2 and IL-23 expression in dendritic cells. EMBO Molecular Medicine 13 (4): e12409.","journal-title":"EMBO Molecular Medicine"},{"issue":"8","key":"1713_CR39","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.it.2004.05.007","volume":"25","author":"H Nakano","year":"2004","unstructured":"Nakano, H. 2004. Signaling crosstalk between NF-kappaB and JNK. Trends in Immunology 25 (8): 402\u2013405.","journal-title":"Trends in Immunology"},{"issue":"11","key":"1713_CR40","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1194\/jlr.M077941","volume":"58","author":"A Rajamoorthi","year":"2017","unstructured":"Rajamoorthi, A., N. Arias, J. Basta, R.G. Lee, and A. Baldan. 2017. Amelioration of diet-induced steatohepatitis in mice following combined therapy with ASO-Fsp27 and fenofibrate. Journal of Lipid Research 58 (11): 2127\u20132138.","journal-title":"Journal of Lipid Research"},{"issue":"12","key":"1713_CR41","doi-asserted-by":"publisher","first-page":"2035","DOI":"10.1002\/hep4.1787","volume":"5","author":"GM Gallucci","year":"2021","unstructured":"Gallucci, G.M., J. Trottier, C. Hemme, D.N. Assis, J.L. Boyer, O. Barbier, and N.S. Ghonem. 2021. Adjunct fenofibrate up-regulates bile acid glucuronidation and improves treatment response for patients with cholestasis. Hepatol Commun 5 (12): 2035\u20132051.","journal-title":"Hepatol Commun"}],"container-title":["Inflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-022-01713-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10753-022-01713-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-022-01713-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,9]],"date-time":"2022-11-09T07:21:47Z","timestamp":1667978507000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10753-022-01713-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,15]]},"references-count":41,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["1713"],"URL":"https:\/\/doi.org\/10.1007\/s10753-022-01713-1","relation":{},"ISSN":["0360-3997","1573-2576"],"issn-type":[{"value":"0360-3997","type":"print"},{"value":"1573-2576","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,15]]},"assertion":[{"value":"23 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"DECLARATIONS"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}